Exact Mass: 301.0563

Exact Mass Matches: 301.0563

Found 138 metabolites which its exact mass value is equals to given mass value 301.0563, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fenhexamid

N-(2,3-Dichloro-4-hydroxyphenyl)-1-methylcyclohexane-1-carboxamide

C14H17Cl2NO2 (301.0636)


   

N-Acetyl-glucosamine 1-phosphate

{[(3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetyl-glucosamine 1-phosphate is an intermediate in aminosugar metabolism. It is a substrate for the enzymes phosphoglucomutase 3 [EC:5.4.2.2 and EC:5.4.2.3] and UDP-N-acteylglucosamine pyrophosphorylase 1 [EC:2.7.7.23] (KEGG). It is involved in UDP-N-acetyl-D-glucosamine biosynthesis and UDP-N-acetylgalactosamine biosynthesis (BioCyc). N-Acetyl-glucosamine 1-phosphate is an intermeiate in the Aminosugars metabolism, a substrate for the enzymes phosphoglucomutase 3 [EC:5.4.2.2 5.4.2.3] and UDP-N-acteylglucosamine pyrophosphorylase 1 [EC:2.7.7.23] (KEGG), in UDP-N-acetyl-D-glucosamine biosynthesis and UDP-N-acetylgalactosamine biosynthesis (BioCyc) [HMDB] COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N-Acetyl-D-Glucosamine 6-Phosphate

{[(2R,3S,4R,5R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetyl-D-Glucosamine 6-Phosphate is an intermediate in the metabolism of Aminosugars. It is a substrate for Glucosamine 6-phosphate N-acetyltransferase. [HMDB] N-Acetyl-D-Glucosamine 6-Phosphate is an intermediate in the metabolism of Aminosugars. It is a substrate for Glucosamine 6-phosphate N-acetyltransferase. KEIO_ID A144

   

N-Acetylglucosamine 6-sulfate

N-Acetyl-D-glucosamine 6-sulfate

C8H15NO9S (301.0468)


   

N-Acetylglucosamine 4-sulfate

N-Acetylgalactosamine 4-sulphate

C8H15NO9S (301.0468)


   

Nocodazole

(5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl)-carbamic acid methyl ester

C14H11N3O3S (301.0521)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents Same as: D05197

   

N-Acetylgalactosamine 4-sulphate

N-[(2R,3R,4R,5R,6R)-2,4-Dihydroxy-6-(hydroxymethyl)-5-(sulphooxy)oxan-3-yl]ethanimidic acid

C8H15NO9S (301.0468)


Also known as GalNAc4S, this molecule is a key component of dermatan, keratan and chondroitin sulfate. It is also a substrate for the enzyme N-acteylgalactosamine-4-sulphate transferase. This molecule is found in elevated concentrations in the urine of patients suffering from muchopolysaccharidosis type III, IV and VI. Levels are typically 300-400 times normal values. GalNAc4S is thought to be derived from the action of beta-N-acetylhexosaminidase on sulphated GlcNAc or GalNAc residues at the non-reducing end of keratan sulphate, dermatan sulphate or chondroitin sulphate. [HMDB] Also known as GalNAc4S, this molecule is a key component of dermatan, keratan and chondroitin sulfate. It is also a substrate for the enzyme N-acteylgalactosamine-4-sulphate transferase. This molecule is found in elevated concentrations in the urine of patients suffering from muchopolysaccharidosis type III, IV and VI. Levels are typically 300-400 times normal values. GalNAc4S is thought to be derived from the action of beta-N-acetylhexosaminidase on sulphated GlcNAc or GalNAc residues at the non-reducing end of keratan sulphate, dermatan sulphate or chondroitin sulphate.

   

N-Acetyl-D-mannosamine 6-phosphate

{[(2R,3S,4R,5S,6S)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetyl-D-mannosamine 6-phosphate is an intermediate in amino sugar metabolism and is a substrate for UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase, Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, Alpha-N-acetylglucosaminidase and Exostosin-2. It can be generated from N-acetyl-neuraminate-9-phosphate or N-acetyl-D-mannosamine. [HMDB] N-Acetyl-D-mannosamine 6-phosphate is an intermediate in amino sugar metabolism and is a substrate for UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase, Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, Alpha-N-acetylglucosaminidase and Exostosin-2. It can be generated from N-acetyl-neuraminate-9-phosphate or N-acetyl-D-mannosamine.

   

N-acetyl-alpha-D-galactosamine 1-phosphate

N-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(phosphonooxy)oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


N-acetyl-alpha-d-galactosamine 1-phosphate is part of the Galactose metabolism, and Amino sugar and nucleotide sugar metabolism pathways. It is a substrate for: N-acetylgalactosamine kinase.

   

Benoxaprofen

()-2-(4-chlorophenyl)benzoxazole-5-propionic acid

C16H12ClNO3 (301.0506)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

   

N-Acetylglucosamine 1-phosphate

N-Acetyl-alpha-D-glucosamine 1-phosphate

C8H16NO9P (301.0563)


KEIO_ID A122

   

N-Acetylgalactosamine 6-sulfate

N-Acetyl-D-galactosamine 6-sulfate

C8H15NO9S (301.0468)


KEIO_ID A184

   

N-Acetyl-D-galactosamine 6-phosphate

N-Acetyl-D-galactosamine 6-phosphate

C8H16NO9P (301.0563)


   

N-acetyl-alpha-D-hexosamine 1-phosphate

N-acetyl-alpha-D-hexosamine 1-phosphate

C8H16NO9P (301.0563)


   

N-Acetylglucosamine 6-sulfate

{[(2R,3S,4R,5R,6R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}sulfonic acid

C8H15NO9S (301.0468)


N-acetylglucosamine 6-sulfate is a physiological intermediate during the degradation of keratan sulfate and it is usually hydrolyzed intralysosomally by N-acetylglucosamine-6-sulfate sulfatase. (PMID 3161730) [HMDB] N-acetylglucosamine 6-sulfate is a physiological intermediate during the degradation of keratan sulfate and it is usually hydrolyzed intralysosomally by N-acetylglucosamine-6-sulfate sulfatase. (PMID 3161730).

   

N-Acetylgalactosamine 6-sulfate

N-[(2R,3R,4R,5R)-3,4,5-Trihydroxy-1-oxo-6-(sulphooxy)hexan-2-yl]ethanimidic acid

C8H15NO9S (301.0468)


N-Acetylgalactosamine 6-sulfate is found in keratan sulfate and chondroitin 6-sulfate. PMID: 12489154. Morquio syndrome is caused by an abnormal accumulation of mucopolysaccharides - in this case, keratan sulfate - in the body. Keratan sulfate is excreted in urine. The symptoms vary from patient to patient, and may include hearing loss, cataracts, skeletal dysplasia, spinal instability, and minor respiratory issues, among others. Two forms are recognized, type A and type B. Type A is a deficiency of the enzyme N-acetylgalactosamine-6-sulfate sulfatase. (Wikipedia). N-Acetylgalactosamine 6-sulfate is found in keratan sulfate and chondroitin 6-sulfate.

   

N-Acetylglucosamine 6-phosphate

{[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetylglucosamine 6-phosphate (CAS: 1746-32-3), also known as GlcNAc6P, belongs to the class of organic compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through an N-acyl group. Outside of the human body, N-acetylglucosamine 6-phosphate has been detected, but not quantified in, several different foods, such as butternut squash, breakfast cereals, babassu palms, vaccinium (blueberry, cranberry, huckleberry), and cauliflowers. This could make N-acetylglucosamine 6-phosphate a potential biomarker for the consumption of these foods. N-Acetylglucosamine 6-phosphate has been identified in the human placenta (PMID: 32033212).

   

N-Acetyl-D-galactosamine 1-phosphate

{[(3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetyl-D-galactosamine 1-phosphate is an intermediate in amino sugar metabolism. The enzyme UDP-N-acetylgalactosamine diphosphorylase catalyzes the conversion of this metabolite into UDP-N-acetyl-D-galactosamine. In the same pathway, the enzyme N-acetylgalactosamine kinase catalyzes the phosphorylation of this metabolite from N-Acetyl-D-galactosamine using ATP or ITP. These two reactions are irreversible and occur in the cytosol. (BiGG database) [HMDB] N-Acetyl-D-galactosamine 1-phosphate is an intermediate in amino sugar metabolism. The enzyme UDP-N-acetylgalactosamine diphosphorylase catalyzes the conversion of this metabolite into UDP-N-acetyl-D-galactosamine. In the same pathway, the enzyme N-acetylgalactosamine kinase catalyzes the phosphorylation of this metabolite from N-Acetyl-D-galactosamine using ATP or ITP. These two reactions are irreversible and occur in the cytosol. (BiGG database).

   

N-Acetylmannosamine-6P

{[(2R,3S,4R,5S,6R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetylmannosamine-6P, also known as N-​acetylmannosamine 6-​phosphate or ManNAc-6-P, is a member of the class of compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through an N-acyl group. N-Acetylmannosamine-6P is soluble (in water) and a moderately acidic compound (based on its pKa).

   

2-(Acetylamino)-2-Deoxy-6-O-Sulfo-alpha-D-Glucopyranose

N-{2,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-3-yl}ethanimidic acid

C8H15NO9S (301.0468)


   

2-Chloroadenosine

2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12ClN5O4 (301.0578)


   

3,4-Dehydrochlorambucil

4-{4-[bis(2-chloroethyl)amino]phenyl}but-3-enoic acid

C14H17Cl2NO2 (301.0636)


   

8-Chloroadenosine

2-(6-amino-8-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12ClN5O4 (301.0578)


   

Benoxaprofen

2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid

C16H12ClNO3 (301.0506)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

   

(5-Acetamido-3,4,6-trihydroxyoxan-2-yl)methyl dihydrogen phosphate

(5-Acetamido-3,4,6-trihydroxyoxan-2-yl)methyl dihydrogen phosphate

C8H16NO9P (301.0563)


   

N-Acetyl-D-mannosamine 6-phosphate

N-Acetyl-D-mannosamine 6-phosphate

C8H16NO9P (301.0563)


   

N-Acetyl-D-galactosamine 4-sulfate

N-Acetyl-D-galactosamine 4-sulfate

C8H15NO9S (301.0468)


   

(2-TRIFLUOROMETHYL-QUINOLIN-4-YLSULFANYL)-ACETIC ACID HYDRAZIDE

(2-TRIFLUOROMETHYL-QUINOLIN-4-YLSULFANYL)-ACETIC ACID HYDRAZIDE

C12H10F3N3OS (301.0497)


   
   
   
   
   

CHEMBL2419350

CHEMBL2419350

C15H11NO6 (301.0586)


   

N-Acetyl-D-glucosamine 1-phosphate

N-Acetyl-D-glucosamine 1-phosphate

C8H16NO9P (301.0563)


   

[(2R,3S,4R,5R)-5-acetamido-2,3,4-trihydroxy-6-oxo-hexoxy]phosphonic acid

[(2R,3S,4R,5R)-5-acetamido-2,3,4-trihydroxy-6-oxo-hexoxy]phosphonic acid

C8H16NO9P (301.0563)


   

Fenhexamid

Fenhexamid

C14H17Cl2NO2 (301.0636)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3057

   

N-Acetylgalactosamine 4-sulphate

N-Acetylgalactosamine 4-sulphate

C8H15NO9S (301.0468)


   

2-Chloroadenosine

2-Chloroadenosine

C10H12ClN5O4 (301.0578)


2-Chloroadenosine, a stable adenosine analogue, protects against long term development of ischaemic cell loss in the rat hippocampus. 2-Chloroadenosine is an apparent competitive inhibitor of uridine influx (apparent Ki=33 μM) and high-affinity nitrobenzylthioinosine binding (apparent Ki=0.18 mM). 2-Chloroadenosine is a transported permeant for the nucleoside transporter in human erythrocytes[1][2].

   

3-Hydroxy-7-aminoclonazepam

3-Hydroxy-7-aminoclonazepam

C15H12ClN3O2 (301.0618)


   

N-Acetylglucosamine-6-phosphate

N-Acetylglucosamine-6-phosphate

C8H16NO9P (301.0563)


   

4-Aminophenyl 1-thio-β-D-glucuronide

4-Aminophenyl 1-thio-β-D-glucuronide

C12H15NO6S (301.062)


   

2-CADO

(2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

C10H12ClN5O4 (301.0578)


2-Chloroadenosine, a stable adenosine analogue, protects against long term development of ischaemic cell loss in the rat hippocampus. 2-Chloroadenosine is an apparent competitive inhibitor of uridine influx (apparent Ki=33 μM) and high-affinity nitrobenzylthioinosine binding (apparent Ki=0.18 mM). 2-Chloroadenosine is a transported permeant for the nucleoside transporter in human erythrocytes[1][2].

   

N-Acetyl-D-galactosamine 1-phosphate

N- Acetyl-alpha-delta-galactosamine 1-phosphate

C8H16NO9P (301.0563)


A D-galactosamine 1-phosphate compound having an N-acetyl substituent.

   

3,4-Dehydrochlorambucil

3,4-Dehydrochlorambucil

C14H17Cl2NO2 (301.0636)


   

N-acetyl-alpha-D-galactosamine 1-phosphate

N-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(phosphonooxy)oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


The alpha-anomer of N-acetyl-D-galactosamine 1-phosphate.

   

7-chloro-4-hydroxy-3-(4-methoxyphenyl)-1H-quinolin-2-one

7-chloro-4-hydroxy-3-(4-methoxyphenyl)-1H-quinolin-2-one

C16H12ClNO3 (301.0506)


   

1-Benzhydryl-3-bromoazetidine

1-Benzhydryl-3-bromoazetidine

C16H16BrN (301.0466)


   

(1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol hydrochloride

(1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol hydrochloride

C11H13Cl2N5O (301.0497)


   

4-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID

4-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID

C12H15NO6S (301.062)


   

1-[3-(4-Bromo-2-fluorophenoxy)propyl]pyrrolidine

1-[3-(4-Bromo-2-fluorophenoxy)propyl]pyrrolidine

C13H17BrFNO (301.0477)


   

4-[(1,3-dioxybutyl)amino]-5-methoxy-2-methyl-benzenesulfonic acid

4-[(1,3-dioxybutyl)amino]-5-methoxy-2-methyl-benzenesulfonic acid

C12H15NO6S (301.062)


   

ethyl 2-[(2-chloroacetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

ethyl 2-[(2-chloroacetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C13H16ClNO3S (301.0539)


   

N-[(4-Methylphenyl)sulfonyl]-L-glutamic acid

N-[(4-Methylphenyl)sulfonyl]-L-glutamic acid

C12H15NO6S (301.062)


   

1-Benzenesulfonyl-1h-indole-7-boronic acid

1-Benzenesulfonyl-1h-indole-7-boronic acid

C14H12BNO4S (301.058)


   

ethyl 4-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-6-yl)benzoate

ethyl 4-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-6-yl)benzoate

C15H12ClN3O2 (301.0618)


   

sodium,2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate,prop-2-enoic acid

sodium,2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate,prop-2-enoic acid

C10H16NNaO6S (301.0596)


   

(Z)-2-BENZAMIDO-3-(2-CHLOROPHENYL)ACRYLIC ACID

(Z)-2-BENZAMIDO-3-(2-CHLOROPHENYL)ACRYLIC ACID

C16H12ClNO3 (301.0506)


   

N-(4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)acetamide-d4

N-(4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)acetamide-d4

C11H7D4N3O3S2 (301.0493)


   

1-Benzenesulfonyl-1H-indole-3-boronic acid

1-Benzenesulfonyl-1H-indole-3-boronic acid

C14H12BNO4S (301.058)


   

Ethyl 4-hydroxy-8-(trifluoromethoxy)quinoline-3-carboxylate

Ethyl 4-hydroxy-8-(trifluoromethoxy)quinoline-3-carboxylate

C13H10F3NO4 (301.0562)


   

(1-(PHENYLSULFONYL)-1H-INDOL-5-YL)BORONIC ACID

(1-(PHENYLSULFONYL)-1H-INDOL-5-YL)BORONIC ACID

C14H12BNO4S (301.058)


   

ETHYL 2-CHLORO-2-(2-(4-METHOXY-2-NITROPHENYL)HYDRAZONO)ACETATE

ETHYL 2-CHLORO-2-(2-(4-METHOXY-2-NITROPHENYL)HYDRAZONO)ACETATE

C11H12ClN3O5 (301.0465)


   

2-(Butyryloxy)-N,N,N-trimethylethanaminium iodide

2-(Butyryloxy)-N,N,N-trimethylethanaminium iodide

C9H20INO2 (301.0539)


   

Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate

Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate

C13H10F3NO4 (301.0562)


   

1-(phenylsulfonyl)-2-indoleboronic acid

1-(phenylsulfonyl)-2-indoleboronic acid

C14H12BNO4S (301.058)


   

1-(2-CHLORO-3-PYRIDYL)-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE

1-(2-CHLORO-3-PYRIDYL)-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE

C14H11ClF3NO (301.0481)


   

2-BROMO-5-FLUORO-N,N-DIISOPROPYLBENZAMIDE

2-BROMO-5-FLUORO-N,N-DIISOPROPYLBENZAMIDE

C13H17BrFNO (301.0477)


   

6-Chloroguanineriboside

6-Chloroguanineriboside

C10H12ClN5O4 (301.0578)


6-Chloroguanineriboside (6-Chloroguanosine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

2-Methoxy-5-(morpholine-4-sulfonyl)-benzoic acid

2-Methoxy-5-(morpholine-4-sulfonyl)-benzoic acid

C12H15NO6S (301.062)


   

3,5-Bis(trifluoromethyl)-DL-phenylalanine

3,5-Bis(trifluoromethyl)-DL-phenylalanine

C11H9F6NO2 (301.0537)


   

1-BENZYL-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

1-BENZYL-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C14H11N3O3S (301.0521)


   

N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-2-cyanoacetamide

N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-2-cyanoacetamide

C15H12ClN3O2 (301.0618)


   

DIMETHYL 5-(N-METHYLMETHYLSULFONAMIDO)ISOPHTHALATE

DIMETHYL 5-(N-METHYLMETHYLSULFONAMIDO)ISOPHTHALATE

C12H15NO6S (301.062)


   

(6-bromopyridin-2-yl)methoxy-tert-butyl-dimethylsilane

(6-bromopyridin-2-yl)methoxy-tert-butyl-dimethylsilane

C12H20BrNOSi (301.0497)


   

4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL

4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C14H11N3O3S (301.0521)


   

(1-(PHENYLSULFONYL)-1H-INDOL-6-YL)BORONIC ACID

(1-(PHENYLSULFONYL)-1H-INDOL-6-YL)BORONIC ACID

C14H12BNO4S (301.058)


   

8-Chloroadenosine

8-Chloroadenosine

C10H12ClN5O4 (301.0578)


8-Chloroadenosine (8-Cl-Ado), a unique ribonucleoside analog, depletes endogenous ATP that subsequently induces the phosphorylation and activation of AMPK. 8-Chloroadenosine induces autophagic cell death. 8-Chloroadenosine effectively inhibited in vivo tumor growth in mice[1]. 8-Chloroadenosine (8-Cl-Ado), a unique ribonucleoside analog, depletes endogenous ATP that subsequently induces the phosphorylation and activation of AMPK. 8-Chloroadenosine induces autophagic cell death. 8-Chloroadenosine effectively inhibited in vivo tumor growth in mice[1].

   
   

(1-(Phenylsulfonyl)-1H-indol-4-yl)boronic acid

(1-(Phenylsulfonyl)-1H-indol-4-yl)boronic acid

C14H12BNO4S (301.058)


   

3-AMINO-3-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID

3-AMINO-3-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID

C11H9F6NO2 (301.0537)


   

4-nitro-N-(phenylthiocarbamoyl)benzamide

4-nitro-N-(phenylthiocarbamoyl)benzamide

C14H11N3O3S (301.0521)


   

N-acetyl-beta-D-glucosamine 6-phosphate

N-acetyl-beta-D-glucosamine 6-phosphate

C8H16NO9P (301.0563)


   

9-(b-D-Arabinofuranosyl)-8-chloroadenine

9-(b-D-Arabinofuranosyl)-8-chloroadenine

C10H12ClN5O4 (301.0578)


   
   

(E)-4-[4-[bis(2-chloroethyl)amino]phenyl]but-3-enoic acid

(E)-4-[4-[bis(2-chloroethyl)amino]phenyl]but-3-enoic acid

C14H17Cl2NO2 (301.0636)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds

   

N-[(3-nitroanilino)-sulfanylidenemethyl]benzamide

N-[(3-nitroanilino)-sulfanylidenemethyl]benzamide

C14H11N3O3S (301.0521)


   

Hydroxythiamine

Hydroxythiamine

C12H16ClN3O2S (301.0652)


D009676 - Noxae > D000963 - Antimetabolites

   

8-Chloro-2-deoxyguanosine

8-Chloro-2-deoxyguanosine

C10H12ClN5O4 (301.0578)


   

Tazobactam trans-enamine intermediate

Tazobactam trans-enamine intermediate

C10H13N4O5S- (301.0607)


   

Tazobactam intermediate

Tazobactam intermediate

C10H13N4O5S- (301.0607)


   

nocodazole

nocodazole

C14H11N3O3S (301.0521)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents Same as: D05197

   

8-Chloroadenosine

2-(6-amino-8-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12ClN5O4 (301.0578)


Calamene is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Calamene is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Calamene can be found in a number of food items such as common oregano, star anise, german camomile, and sweet bay, which makes calamene a potential biomarker for the consumption of these food products.

   

N-Acetyl-D-glucosamine-6-phosphate

[(2R,3S,4R,5R)-5-acetamido-2,3,4-trihydroxy-6-oxo-hexoxy]phosphonic acid

C8H16NO9P (301.0563)


N-acetylglucosamine 6-phosphate, also known as glcnac6p, is a member of the class of compounds known as acylaminosugars. Acylaminosugars are organic compounds containing a sugar linked to a chain through N-acyl group. N-acetylglucosamine 6-phosphate is soluble (in water) and a moderately acidic compound (based on its pKa). N-acetylglucosamine 6-phosphate can be found in a number of food items such as mountain yam, grass pea, rubus (blackberry, raspberry), and angelica, which makes N-acetylglucosamine 6-phosphate a potential biomarker for the consumption of these food products.

   

2-(Acetylamino)-2-Deoxy-6-O-Sulfo-alpha-D-Glucopyranose

N-{2,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-3-yl}ethanimidic acid

C8H15NO9S (301.0468)


   

2-(Acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose

2-(Acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose

C8H15NO9S (301.0468)


   

Methyl 2,2-dichloro-3-hydroxy-4-(methoxycarbonylamino)-5-methylhexanoate

Methyl 2,2-dichloro-3-hydroxy-4-(methoxycarbonylamino)-5-methylhexanoate

C10H17Cl2NO5 (301.0484)


   
   

6-O-Sulfo-2-(acetylamino)-2-deoxy-D-glucopyranose

6-O-Sulfo-2-(acetylamino)-2-deoxy-D-glucopyranose

C8H15NO9S (301.0468)


   

n-Acetylgalactosamine-6-sulfate

n-Acetylgalactosamine-6-sulfate

C8H15NO9S (301.0468)


   

N-acetyl-mannosamine-1-phosphate

N-acetyl-mannosamine-1-phosphate

C8H16NO9P (301.0563)


   

N-Acetyl-alpha-D-glucosamine 3-sulfate

N-Acetyl-alpha-D-glucosamine 3-sulfate

C8H15NO9S (301.0468)


   

aldehydo-N-acetyl-D-mannosamine 6-phosphate

aldehydo-N-acetyl-D-mannosamine 6-phosphate

C8H16NO9P (301.0563)


An aldehydo-N-acyl-D-mannosamine 6-phosphate that has acetyl as the acyl group.

   

2-hydroxy-6-methyl-3-[(E)-3-(3-nitrophenyl)prop-2-enoyl]pyran-4-one

2-hydroxy-6-methyl-3-[(E)-3-(3-nitrophenyl)prop-2-enoyl]pyran-4-one

C15H11NO6 (301.0586)


   

N-(3-(2-Nitrophenyl)-2-propenylidene)-2-thiophenecarbohydrazide

N-(3-(2-Nitrophenyl)-2-propenylidene)-2-thiophenecarbohydrazide

C14H11N3O3S (301.0521)


   

N-benzyl-2,3,4,5,6-pentafluorobenzamide

N-benzyl-2,3,4,5,6-pentafluorobenzamide

C14H8F5NO (301.0526)


   

N-Acetylgalactosamine 4-sulfate

N-Acetyl-D-galactosamine 4-sulfate

C8H15NO9S (301.0468)


   
   

N-acetyl-beta-D-glucosamine 1-phosphate

N-acetyl-beta-D-glucosamine 1-phosphate

C8H16NO9P (301.0563)


   

N-(2,1,3-benzothiadiazol-5-yl)-2,4-dimethyl-6-oxo-3-pyrancarboxamide

N-(2,1,3-benzothiadiazol-5-yl)-2,4-dimethyl-6-oxo-3-pyrancarboxamide

C14H11N3O3S (301.0521)


   

(E)-3-[3-[(4-chlorobenzoyl)amino]phenyl]prop-2-enoic acid

(E)-3-[3-[(4-chlorobenzoyl)amino]phenyl]prop-2-enoic acid

C16H12ClNO3 (301.0506)


   

N-acetyl-beta-D-galactosamine 1-phosphate

N-acetyl-beta-D-galactosamine 1-phosphate

C8H16NO9P (301.0563)


The beta-anomer of N-acetyl-D-galactosamine 1-phosphate.

   

4-Aminophenyl 1-thio-beta-D-glucuronide

4-Aminophenyl 1-thio-beta-D-glucuronide

C12H15NO6S (301.062)


   

[(6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate

[(6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate

C8H16NO9P (301.0563)


   

Benzaldehyde, o-[(pentafluorophenyl)methyl]oxime

Benzaldehyde, o-[(pentafluorophenyl)methyl]oxime

C14H8F5NO (301.0526)


   

3-Phenyl-4-(2,4-difluorobenzoyl)isoxazol-5(4H)-one

3-Phenyl-4-(2,4-difluorobenzoyl)isoxazol-5(4H)-one

C16H9F2NO3 (301.055)


   

3-Phenyl-4-(2,6-difluorobenzoyl)isoxazol-5(4H)-one

3-Phenyl-4-(2,6-difluorobenzoyl)isoxazol-5(4H)-one

C16H9F2NO3 (301.055)


   

3-[(3-Acetyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

3-[(3-Acetyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C8H16NO9P (301.0563)


   

N-Acetyl-alpha-D-glucosamine 1-phosphate

N-Acetyl-alpha-D-glucosamine 1-phosphate

C8H16NO9P (301.0563)


A 2-acetamido-2-deoxy-D-glucopyranose 1-phosphate having alpha-configuration at the anomeric centre.

   

N-Acetyl-D-Glucosamine 6-Phosphate

N-Acetyl-D-Glucosamine 6-Phosphate

C8H16NO9P (301.0563)


An N-acyl-D-glucosamine 6-phosphate that is the N-acetyl derivative of D-glucosamine 6-phosphate. It is a component of the aminosugar metabolism.

   

N-Acetylglucosamine-1-phosphate

2-acetamido-2-deoxy-D-glucopyranose 1-phosphate

C8H16NO9P (301.0563)


A N-acetyl-D-glucosamine 1-phosphate that is 2-deoxy-D-glucopyranose 1-(dihydrogen phosphate) substituted by an acetamido group at position 2. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N-Acetyl-D-galactosamine 6-sulfate

N-Acetyl-D-galactosamine 6-sulfate

C8H15NO9S (301.0468)


   

2-Deoxy-2-acetamido-beta-D-galactose-4-sulfate

2-Deoxy-2-acetamido-beta-D-galactose-4-sulfate

C8H15NO9S (301.0468)


   

2-(Acetylamino)-2-deoxy-6-O-phosphono-alpha-D-mannopyranose

2-(Acetylamino)-2-deoxy-6-O-phosphono-alpha-D-mannopyranose

C8H16NO9P (301.0563)


   

N-Acetylmannosamine-6P

N-Acetylmannosamine-6P

C8H16NO9P (301.0563)


   

N-acetyl-D-hexosamine 1-phosphate

[3-acetylamino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphosphonic acid

C8H16NO9P (301.0563)


   

Dehydrochlorambucil

Dehydrochlorambucil

C14H17Cl2NO2 (301.0636)


   

N-Acetyl-glucosamine 6-phosphate

N-Acetyl-glucosamine 6-phosphate

C8H16NO9P (301.0563)


   
   

Muscarine (iodide)

Muscarine (iodide)

C9H20INO2 (301.0539)


Muscarine ((+)-Muscarine) iodide is a toxin that can stimulate the parasympathetic nervous system. Muscarine iodide is a prototype muscarinic acetylcholine receptor agonist[1][2].

   

n-[(2s,3r,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


   

[(2r,3s,4r,5r,6s)-3,4,6-trihydroxy-5-[(1-hydroxyethenyl)amino]oxan-2-yl]methoxyphosphonic acid

[(2r,3s,4r,5r,6s)-3,4,6-trihydroxy-5-[(1-hydroxyethenyl)amino]oxan-2-yl]methoxyphosphonic acid

C8H16NO9P (301.0563)


   

[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethenyl)amino]-6-(hydroxymethyl)oxan-2-yl]oxyphosphonic acid

[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethenyl)amino]-6-(hydroxymethyl)oxan-2-yl]oxyphosphonic acid

C8H16NO9P (301.0563)


   

n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


   

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-(phosphonooxy)oxan-3-yl]ethanimidic acid

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-(phosphonooxy)oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


   

(3s,3ar)-7-chloro-5-(cyanomethyl)-3a-hydroxy-3h-cyclopenta[a]inden-3-yl acetate

(3s,3ar)-7-chloro-5-(cyanomethyl)-3a-hydroxy-3h-cyclopenta[a]inden-3-yl acetate

C16H12ClNO3 (301.0506)


   

7-hydroxy-8-methoxy-3-methyl-10-oxochromeno[3,2-c]pyridine-9-carboxylic acid

7-hydroxy-8-methoxy-3-methyl-10-oxochromeno[3,2-c]pyridine-9-carboxylic acid

C15H11NO6 (301.0586)


   

n-[(2r,3r,4s,5r)-3,4,5-trihydroxy-1-oxo-6-(phosphonooxy)hexan-2-yl]ethanimidic acid

n-[(2r,3r,4s,5r)-3,4,5-trihydroxy-1-oxo-6-(phosphonooxy)hexan-2-yl]ethanimidic acid

C8H16NO9P (301.0563)


   

n-[(2s,3s,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

n-[(2s,3s,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)